雅本化学入选中上协“上市公司可持续发展优秀案例” 创新药与绿色技术双轮驱动竞争力提升

Core Insights - Yabao Chemical has been recognized as a "2025 Excellent Practice Case for Sustainable Development" by the China Association of Listed Companies, highlighting its achievements in sustainable development and innovation transformation [1] - The company's deep engagement in innovative pharmaceuticals and its green low-carbon transition are becoming key drivers for enhancing its competitiveness [1] Group 1: Sustainable Development Initiatives - Yabao Chemical was one of the first companies in China to implement the DuPont Sustainable Development Program in 2019, investing over 10 million yuan and training more than 100 management personnel [3] - In November 2023, the company committed to the Science Based Targets initiative (SBTi) as one of the first participants in its industry, with a long-term carbon reduction plan set to be officially reviewed by SBTi by June 2025 [3] Group 2: Strategic Focus on Green Technology - The chairman of Yabao Chemical emphasized that sustainable development is at the core of the company's strategy, and it aims to enhance competitiveness through green transformation [5] - The company is advancing green technology research and application in the innovative pharmaceutical sector, focusing on biosynthesis technology to replace traditional chemical synthesis processes, significantly improving the atomic economy of drug synthesis [5] Group 3: Emission Reduction Goals - To meet its SBTi commitment, Yabao Chemical aims to reduce Scope 1 and Scope 2 emissions by 54.9% and Scope 3 emission intensity by 61.1% by 2033, using 2022 as the baseline [6] - The company has implemented systematic emission reduction measures, achieving a 7.6% reduction in total Scope 1 and Scope 2 emissions compared to its target value for 2024 [6] Group 4: Competitive Advantage through Innovation - By integrating scientific carbon goals with innovative pharmaceutical development, Yabao Chemical is building a unique market competitive advantage [6] - Continuous investment in green technology is transforming costs into competitiveness, aligning with global low-carbon development trends and providing new momentum for long-term growth in the innovative pharmaceutical sector [6]